Cullinan Therapeutics, Inc. Common Stock (CGEM) is a publicly traded Healthcare sector company. As of November 4, 2026, CGEM trades at $16.20 with a market cap of $960.82M and a P/E ratio of 0.00. CGEM moved +5.66% today. Year to date, CGEM is +55.64%; over the trailing twelve months it is +101.68%. Its 52-week range spans $5.68 to $23.19. Analyst consensus is strong buy with an average price target of $35.80. Rallies surfaces CGEM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for CGEM, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $16.20 |
| Market Cap | $960.82M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $23.19 |
| 52-Week Low | $5.68 |
| Volume | 617.18K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-219.88M |
| Gross Margin | 0.00% |
12 analysts cover CGEM: 0 strong buy, 12 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $35.80.